Prostate News Archive
11-Jun-2011
FDA: Prostate Cancer Risk From BPH, Hair Drugs
Title: FDA: prostate Cancer Risk From BPH, Hair Drugs Category: Health News Created: 6/10/2011 11:01:00 AM Last Editorial Review: 6/10/2011 Prostate drugs raise risk of prostate cancer: FDA
A class of drugs meant to improve symptoms of an enlarged prostate gland actually increase the chance of getting a more serious form of prostate cancer, health officials said on Thursday. FDA Warns Some Prostate Drugs May Worsen Cancer Risk
The FDA expanded the warning label on certain prostate drugs, warning they may increase the risk of a more severe form of cancer. New Prostate Cancer Drugs Offer Hope
Prostate cancer is the most common cancer among men, usually occurring at or after age 50, and the leading cause of death in men throughout the world. The cancer, which begins in the prostate gland of the male reproductive system, sometimes spreads to the bone and may be resistant to hormonal therapy. FDA links some prostate drugs to cancer risk
The Food and Drug Administration expanded the warning label on a group of prostate drugs Thursday, saying they may increase the risk of a more serious form of prostate cancer.
Back to Prostate News Archive
